Breaking News Instant updates and real-time market news.

EADSY

Airbus

$23.11

0.058 (0.25%)

, AFLYY

Air France-KLM

$15.84

0.11 (0.70%)

06:12
10/13/17
10/13
06:12
10/13/17
06:12

FAA orders A380 engine inspections following Air France incident, Reuters says

The Federal Aviation Administration has ordered inspections of fan hubs in Airbus (EADSY) A380 jet engines after an engine fell apart on an Air France (AFLYY) flight prompting it to make an emergency landing, Reuters reports, citing the agency. Owners and operators of Engine Alliance Model GP7200 series engines, manufactured by a joint venture between General Electric (GE) and United Technologies' (UTX) Pratt & Whitney, must remove the fan hub if defects are discovered. Reference Link

EADSY

Airbus

$23.11

0.058 (0.25%)

AFLYY

Air France-KLM

$15.84

0.11 (0.70%)

GE

General Electric

$23.05

-0.02 (-0.09%)

UTX

United Technologies

$118.82

1.07 (0.91%)

  • 20

    Oct

  • 24

    Oct

EADSY Airbus
$23.11

0.058 (0.25%)

09/22/17
09/22/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Versartis (VSAR) was downgraded to Hold from Buy at SunTrust, to Underweight from Overweight at Barclays, to Neutral from Overweight at Piper Jaffray, and to Market Perform from Outperform at Cowen. 2. Tiffany (TIF) downgraded to Neutral from Buy at Goldman Sachs with analyst Lindsay Drucker Mann saying the company's high-end categories, including engagement, wedding and solitaire jewelry, decelerated in the last two quarters. 3. Airbus (EADSY) downgraded to Hold from Buy at Jefferies with analyst Sandy Morris saying the company's EBIT in fiscal 2018 and fiscal 2019 could track significantly below consensus expectations. 4. Alcoa (AA) downgraded to Hold from Buy at Berenberg with analyst Yuriy Vlasov saying Alcoa shares are up 43% over the past six months and recommends taking profits. 5. U.S. Steel (X) was downgraded to Underperform from Market Perform while ArcelorMittal (MT) was downgraded to Market Perform from Outperform at Cowen. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/21/17
BERN
03/21/17
NO CHANGE
BERN
Airbus shares poised to outperform over the long-term, says Bernstein
Bernstein analyst Douglas Harned expects Airbus' earnings and cash flow growth to accelerate significantly in 2018-2019, enabling the stock to outperform. He raised his price target on the name to EUR88 from EUR83.
09/06/17
STFL
09/06/17
NO CHANGE
STFL
Stifel says United Tech deal strategic, not a sign of M&A 'floodgates opening'
Stifel analyst Joseph DeNardi said one of the only risks he sees to defense stocks' multiples would be a shift in cash deployment strategy from a focus on dividends and buybacks to M&A. However, he views United Technologies' (UTX) planned acquisition of Rockwell Collins (COL) as strategic and largely focused on its desire to regain leverage against Boeing (BA) and Airbus (EADSY) and not indicative of the M&A "floodgates opening" in the defense sector. Other publicly traded companies in the defense space include BAE Systems (BAESY), General Dynamics (GD), Lockheed Martin (LMT), Northrop Grumman (NOC) and Raytheon (RTN).
09/22/17
JEFF
09/22/17
DOWNGRADE
JEFF
Hold
Airbus downgraded to Hold from Buy at Jefferies
Jefferies analyst Sandy Morris downgraded Airbus Group to Hold saying the company's EBIT in FY18 and FY19 could track significantly below consensus expectations. The analyst has a EUR 75 price target on the shares.
AFLYY Air France-KLM
$15.84

0.11 (0.70%)

02/21/17
UBSW
02/21/17
UPGRADE
UBSW
Buy
Air France-KLM upgraded to Buy from Sell at UBS
Price target EUR 7.50.
03/09/17
SOCG
03/09/17
UPGRADE
SOCG
Buy
Air France-KLM upgraded to Buy from Hold at Societe Generale
Price target EUR 9.
06/27/17
RBCM
06/27/17
UPGRADE
RBCM
Outperform
Air France-KLM upgraded to Outperform from Sector Perform at RBC Capital
Price target EUR 20.
02/20/17
SBSH
02/20/17
UPGRADE
SBSH
Buy
Air France-KLM upgraded to Buy from Neutral at Citi
Price target EUR 7.50.
GE General Electric
$23.05

-0.02 (-0.09%)

10/05/17
MSCO
10/05/17
NO CHANGE
Target $25
MSCO
Equal Weight
General Electric likely to cut FY17 EPS view below $1.50, says Morgan Stanley
Morgan Stanley analyst Nigel Coe said he expects General Electric to lower its FY17 EPS guidance to below $1.50 per share from its currently stated view of $1.60-$1.70 when the company reports earnings on October 20. The analyst, who has $1.40 EPS forecast for the full year, also expects GE to reduce its $12B-$14B CFOA target to closer to $11B and sees scope for the buyback program to be scaled back. Coe, who is not certain if all of this is priced into the stock, is "tactically cautious" into the report and keeps an Equal Weight rating and $25 target price on GE shares.
10/09/17
SBSH
10/09/17
NO CHANGE
Target $31
SBSH
Buy
Citi 'glass half-full' on General Electric management changes
Citi analyst Andrew Kaplowitz says he's taking a "glass half-full" view on General Electric's leadership changes. The analyst is surprised at the "relatively quick" departure of Vice Chair and CFO Jeffrey Bornstein, but believes CEO John Flannery and GE as a whole are effecting a "clean break" from the past. While bears may view the announcement as another signal that GE's recovery could be slower than expected, the changes "likely represent a necessary step toward a more accountable, streamlined, GE," Kaplowitz tells investors in a research note. He keeps a Buy rating on the shares with a $31 price target.
10/09/17
JPMS
10/09/17
NO CHANGE
JPMS
Underweight
GE changes suggest fundamentals worse than expected, says JPMorgan
JPMorgan analyst C. Stephen Tusa believes the management changes announced Friday night by General Electric reinforce his view that the company's core fundamental challenges are "worse than consensus is currently discounting." The analyst keeps an Underweight rating on the shares.
10/11/17
JPMS
10/11/17
NO CHANGE
Target $20
JPMS
Underweight
JPMorgan says GE dividend cut 'increasingly likely,' drops target to $20
JPMorgan analyst C. Stephen Tusa believes a dividend cut at General Electric is "increasingly likely" after the analyst again reduced his estimates. Tusa lowered his estimates to reflect reduced revenues and profits in the Power and Oil & Gas segment as well as higher restructuring expenses. The analyst cut his price target for GE shares to $20 from $22 and keeps an Underweight rating on the name. The stock closed yesterday down 6c to $23.36. With recently added Board members potentially pushing for a quick fix, with all outcomes on the table, a more comprehensive breakup is possible, Tusa tells investors in a research note titled "'Terminal Value': Cutting Numbers, Price Target, and Value of Power in Sum of the Parts." His non-GAAP earnings per share estimates now sit at $1.40/$1.25/$1.40/$1.50 for 2017/2018/2019/2020.
UTX United Technologies
$118.82

1.07 (0.91%)

09/07/17
WOLF
09/07/17
DOWNGRADE
WOLF
Peer Perform
Rockwell Collins downgraded to Peer Perform from Outperform at Wolfe Research
Wolfe Research analyst Hunter Keay downgraded yesterday afternoon Rockwell Collins (COL) to Peer Perform following the company's agreement to be acquired by United Technologies (UTX).
09/11/17
BERN
09/11/17
DOWNGRADE
Target $137
BERN
Market Perform
Rockwell Collins downgraded to Market Perform from Outperform at Bernstein
Bernstein analyst Douglas Harned downgraded Rockwell Collins (COL) to Market Perform from Outperform following its board approval of United Technologies' (UTX) planned acquisition at a nominal price of $140/share. The analyst says the stock has moved above $130 related to the deal, and he is concerned that Rockwell Collins' acceptance of a $140 deal price indicates that internal forecasts are more pessimistic than his. He kept a $137 price target on Rockwell Collin's shares, but lowered hist target for United Technologies to $126 from $135, while reiterating a Market-Perform rating.
09/13/17
BARD
09/13/17
DOWNGRADE
BARD
Neutral
Rockwell Collins downgraded to Neutral from Outperform at Baird
Baird analyst Peter Arment downgraded Rockwell Collins (COL) to Neutral from Outperform following its board approval of United Technologies' (UTX) planned acquisition at a nominal price of $140 per share.

TODAY'S FREE FLY STORIES

19:15
10/20/17
10/20
19:15
10/20/17
19:15
General news
Breaking General news story  »

Federal Reserve Chair…

ATRS

Antares Pharma

$2.18

0.06 (2.83%)

18:59
10/20/17
10/20
18:59
10/20/17
18:59
Hot Stocks
FDA cannot approve Antares Pharma's Xyosted NDA »

Antares Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

18:55
10/20/17
10/20
18:55
10/20/17
18:55
Conference/Events
Federal Reserve Chairperson delivers a lecture at NEC Dinner »

Federal Reserve…

SHIP

Seanergy Marine

$1.24

0.0199 (1.63%)

17:50
10/20/17
10/20
17:50
10/20/17
17:50
Syndicate
Breaking Syndicate news story on Seanergy Marine »

Seanergy Marine files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLI

Houlihan Lokey

$41.56

0.18 (0.43%)

17:49
10/20/17
10/20
17:49
10/20/17
17:49
Syndicate
Breaking Syndicate news story on Houlihan Lokey »

Houlihan Lokey files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

GEO

Geo Group

$26.20

0.2 (0.77%)

17:48
10/20/17
10/20
17:48
10/20/17
17:48
Syndicate
Breaking Syndicate news story on Geo Group »

Geo Group files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

, AIMT

Aimmune

$25.66

-0.06 (-0.23%)

17:37
10/20/17
10/20
17:37
10/20/17
17:37
Hot Stocks
DBV sinks following peanut allergy trial miss, Aimmune soars »

Shares of DBV…

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

AIMT

Aimmune

$25.66

-0.06 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

KALV

KalVista

$11.26

1.99 (21.47%)

, DBVT

DBV Technologies

$48.07

0.92 (1.95%)

17:24
10/20/17
10/20
17:24
10/20/17
17:24
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: KalVista (KALV),…

KALV

KalVista

$11.26

1.99 (21.47%)

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPCI

Intellipharmaceutics

17:23
10/20/17
10/20
17:23
10/20/17
17:23
Hot Stocks
Breaking Hot Stocks news story on Intellipharmaceutics »

Armistice Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

17:21
10/20/17
10/20
17:21
10/20/17
17:21
Hot Stocks
DBV Technologies: PEPITES trial does not reach primary endpoint »

DBV Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$54.92

1.17 (2.18%)

17:08
10/20/17
10/20
17:08
10/20/17
17:08
Periodicals
Regulator criticizes Wells Fargo over deceptive auto insurance program, NYT says »

The Office of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 02

    Nov

  • 07

    Nov

  • 29

    Nov

  • 15

    Jan

ALIM

Alimera Sciences

17:01
10/20/17
10/20
17:01
10/20/17
17:01
Syndicate
Alimera Sciences to sell $25M in shares in an 'at the market offering' »

On October 20, Alimera…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYMC

Symantec

$32.66

0.33 (1.02%)

16:51
10/20/17
10/20
16:51
10/20/17
16:51
Syndicate
Breaking Syndicate news story on Symantec »

Symantec files to sell 1M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

EBMT

Eagle Bancorp

$19.55

0.15 (0.77%)

16:44
10/20/17
10/20
16:44
10/20/17
16:44
Hot Stocks
Breaking Hot Stocks news story on Eagle Bancorp »

EJF Capital reports 7%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KALV

KalVista

$11.26

1.99 (21.47%)

16:43
10/20/17
10/20
16:43
10/20/17
16:43
Hot Stocks
Breaking Hot Stocks news story on KalVista »

Longwood Fund II reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JAGX

Jaguar Health

$0.19

0.002 (1.08%)

16:41
10/20/17
10/20
16:41
10/20/17
16:41
Syndicate
Breaking Syndicate news story on Jaguar Health »

Jaguar Health files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$345.10

-6.71 (-1.91%)

16:40
10/20/17
10/20
16:40
10/20/17
16:40
Hot Stocks
Tesla amends 'warehouse agreements' to increase commitments to $1.1B »

On October 18,Tesla…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 06

    Nov

SNV

Synovus

$47.30

0.54 (1.15%)

16:38
10/20/17
10/20
16:38
10/20/17
16:38
Hot Stocks
Synovus CBO sells 10,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Nov

  • 15

    Nov

GTXI

GTx

$7.92

0.1 (1.28%)

16:38
10/20/17
10/20
16:38
10/20/17
16:38
Syndicate
Breaking Syndicate news story on GTx »

GTx files to sell 8.77M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASB

Associated Banc-Corp

$25.90

1.3 (5.28%)

, BKMU

BankMutual

$10.80

0.55 (5.37%)

16:36
10/20/17
10/20
16:36
10/20/17
16:36
Conference/Events
BankMutual to host special shareholder meeting »

Special Shareholder…

ASB

Associated Banc-Corp

$25.90

1.3 (5.28%)

BKMU

BankMutual

$10.80

0.55 (5.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

CNXR

Connecture

$0.49

-0.01 (-2.00%)

16:35
10/20/17
10/20
16:35
10/20/17
16:35
Hot Stocks
Breaking Hot Stocks news story on Connecture »

Connecture trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$23.83

0.25 (1.06%)

, PG

Procter & Gamble

$88.25

-3.34 (-3.65%)

16:31
10/20/17
10/20
16:31
10/20/17
16:31
General news
On The Fly: Top stock stories for Friday »

Stocks opened sharply…

GE

General Electric

$23.83

0.25 (1.06%)

PG

Procter & Gamble

$88.25

-3.34 (-3.65%)

CELG

Celgene

$121.33

-14.63 (-10.76%)

SNCR

Synchronoss

$11.39

-0.12 (-1.04%)

IL

Bought by SNCR

SKX

Skechers

$33.99

9.96 (41.45%)

PYPL

PayPal

$70.97

3.72 (5.53%)

NCR

NCR Corp.

$33.05

-4 (-10.80%)

LHO

LaSalle Hotel

$28.52

-1.94 (-6.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 22

    Oct

  • 26

    Oct

  • 28

    Oct

  • 06

    Nov

  • 08

    Nov

  • 08

    Nov

  • 29

    Nov

  • 30

    Nov

16:30
10/20/17
10/20
16:30
10/20/17
16:30
Options
Preliminary option volume of 22.9M today »

Preliminary option volume…

MKL

Markel

$1,078.23

14.88 (1.40%)

, SNC

State National

$21.05

0.02 (0.10%)

16:26
10/20/17
10/20
16:26
10/20/17
16:26
Conference/Events
State National to host special shareholder meeting »

Special Shareholder…

MKL

Markel

$1,078.23

14.88 (1.40%)

SNC

State National

$21.05

0.02 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 26

    Oct

RYTM

Rhythm Pharmaceuticals

$23.08

-0.17 (-0.73%)

16:22
10/20/17
10/20
16:22
10/20/17
16:22
Hot Stocks
Breaking Hot Stocks news story on Rhythm Pharmaceuticals »

Orbimed Advisors reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.